Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors.

ABSTRACT:

Background

There is a paucity of data on heart transplantation (HT) using COVID-19 donors.

Objectives

This study investigated COVID-19 donor use, donor and recipient characteristics, and early post-HT outcomes.

Methods

Between May 2020 and June 2022, study investigators identified 27,862 donors in the United Network for Organ Sharing, with 60,699 COVID-19 nucleic acid amplification testing (NAT) performed before procurement and with available organ disposition. Donors were considered "COVID-19 donors" if they were NAT positive at any time during terminal hospitalization. These donors were subclassified as "active COVID-19" (aCOV) donors if they were NAT positive within 2 days of organ procurement, or "recently resolved COVID-19" (rrCOV) donors if they were NAT positiv

SUBMITTER: Madan S 

PROVIDER: S-EPMC10191151 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature